May 30, 2017 13:20 pm UTC| Business
BOSTON, May 30, 2017 -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced it will webcast its corporate...
May 30, 2017 13:20 pm UTC| Business
MILAN, Italy, May 30, 2017 -- The luxury market is set to get back to growth in 2017. A firm Chinese rebound with purchasing both at home and overseas as well as increasing customer confidence in Europe will boost...
May 30, 2017 13:20 pm UTC| Business
BOSTON, May 30, 2017 -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced it will webcast its corporate...
May 30, 2017 13:20 pm UTC| Business
BOSTON, May 30, 2017 -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced it will webcast its corporate...
May 30, 2017 13:20 pm UTC| Business
BOSTON, May 30, 2017 -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced it will webcast its corporate...
May 30, 2017 13:20 pm UTC| Business
BOSTON, May 30, 2017 -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced it will webcast its corporate...
May 30, 2017 13:20 pm UTC| Business
BOSTON, May 30, 2017 -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today announced it will webcast its corporate...
Viksit Bharat 2026: Fiscal Muscle, Factory Revival, and the War on Speculation